MICHAEL JOHNSON to Longitudinal Studies
This is a "connection" page, showing publications MICHAEL JOHNSON has written about Longitudinal Studies.
Connection Strength
0.460
-
Regression coefficient-based scoring system should be used to assign weights to the risk index. J Clin Epidemiol. 2016 11; 79:22-28.
Score: 0.101
-
Use of Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Risk of Dementia in Heart Failure. Am J Alzheimers Dis Other Demen. 2016 08; 31(5):395-404.
Score: 0.098
-
Use of Statins and Risk of Dementia in Heart Failure: A Retrospective Cohort Study. Drugs Aging. 2015 Sep; 32(9):743-54.
Score: 0.096
-
Risk factors for dementia in patients over 65 with diabetes. Int J Geriatr Psychiatry. 2011 Jul; 26(7):749-57.
Score: 0.068
-
Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular disease. Am J Manag Care. 2004 Dec; 10(12):926-32.
Score: 0.046
-
Comparative treatment effectiveness of oral fingolimod and conventional injectable disease-modifying agents in multiple sclerosis. Pharmacotherapy. 2021 05; 41(5):440-450.
Score: 0.035
-
Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients. Am J Geriatr Pharmacother. 2008 Oct; 6(4):198-204.
Score: 0.015